Abstract: Reference limits are estimators for 'extreme' percentiles of the distribution of a quantitative diagnostic marker in the healthy population. In most cases, interest will be in the 90% or 95% reference intervals. The standard parametric method of determining reference limits consists of computing quantities of the form X ̅ ± c·S. The proportion of covered values in the underlying population coincides with the specificity obtained when a measurement value falling outside the corresponding reference region is classified as diagnostically suspect. Nonparametrically, reference limits are estimated by means of so-called order statistics. In both approaches, the precision of the estimate depends on the sample size. We present computational procedures for calculating minimally required numbers of subjects to be enrolled in a reference study. The much more sophisticated concept of reference bands replacing statistical reference intervals in case of age-dependent diagnostic markers is also discussed.
Introduction
Reference limits are an indispensable tool of medical diagnostics by means of quantitative laboratory tests. Without reference limits which have been established by means of well-grounded statistical rules and procedures, quantitative diagnostic methods would be of little if any use for clinical practice. Except for cases where clinical decision limits are available, comparison with reference limits is currently clearly the major approach to the clinical interpretation of laboratory data. Speaking in general terms, a result of a quantitative laboratory test is classified as being diagnostically suspect if it falls in a range of values which have to be considered as extreme, in the sense, that there is only a small proportion of subjects in the healthy population providing values which are still larger or smaller. The proportion of values in the reference population exceeding these reference limits are usually fixed at 5.0% or 2.5%, depending on whether deviations from the mean to only one direction are supposed to have diagnostic relevance, or both too small and too large values are potentially pathologic. The proportion of values measured in healthy subjects which do not fall outside the reference interval is called the coverage of the latter. The coverage proportion coincides with the specificity [1] of the corresponding diagnostic decision rule being equal to 95% when the reference limits are set in the way described before. Thus, if for a given diagnostic test higher specificity is needed the reference interval may be enlarged. It is important to note that observing a value beyond the reference limits must not be taken as definitely indicating that a subject suffers from the disease under consideration. Such values also occur in non-diseased individuals but at a low frequency.
In the following, we will focus on statistical considerations about the planning of studies to determine reference limits and in particular the estimation of the appropriate sample size. The present review should aid clinical researchers in the design of such studies. Detailed considerations about the correct definition of reference individuals and their health status are outside the scope of this review. Both selection strategies and statistical criteria are potentially useful for avoiding inclusion of values from individuals in a reference sample who actually belong to a diseased subpopulation. Selection strategies are based on filters tailored for recognizing individuals of whom it has to be suspected that they suffer from a disease influencing the marker under investigation. Examples of such a filter are repeated hospitalization prior to blood sampling and extreme values of other diagnostic tests. Statistically, a mandatory step is the elimination of outliers. However, one has to be aware of the fact that non-inclusion of outlying values is only a necessary but not a sufficient condition for representativeness for the non-diseased population.
Basic options for determining reference limits

Parametric approach
Stated in statistical language, reference limits are quantiles or percentiles of the probability distribution which the diagnostic marker under evaluation follows in the population of non-diseased individuals. If this distribution is Gaussian with population mean μ and variance σ 2 , the true reference limits are given by the numbers μ ± c·σ, where in the one-and two-sided case c has to be set equal to 1.645 and 1.960, respectively. It should be noted that the parametric approach requires a normal distribution either of the primary measurement values or some suitable transform of them. The statistical literature contains a wealth of different proposals for checking normality of distributions. Among the most recommendable criteria is a combination of the skewness and kurtosis statisticsfor details see [2] . As holds generally true in parametric statistics, μ and σ 2 are unknown constants which have to be estimated from empirical data. Assuming that one has to deal with a single diagnostic marker X which does not depend on additional variables (in particular on age), the data obtained from a reference value study consists of a list X 1 ,...,X n of n values measured in subjects that should be ideally free of the disease to be diagnosed by means of X. Estimating the reference limits simply requires substituting the sample mean X ̅ and the empirical standard deviation S for their population analogs μ and σ using X ̅ -c·S and X ̅ +c·S as empirical lower and upper reference limit, respectively. A crucial point to be observed in carrying out these very simple computations is that the factor c is the same for the reference limits estimated from empirical data as for the theoretical limits which would have to be used if the underlying population were completely known. This means, in particular, that c need not be replaced with a quantity which depends on the sample size as has to be used in computing confidence limits for μ [3] which depend on the standard error of the mean rather than the standard deviation of a single observation. Actually, a reference interval is in general substantially wider than the corresponding confidence interval (CI).
Nonparametric estimation
Whenever the distribution of X exhibits features which are not consistent with the Gaussian model and cannot be removed through applying some known transformation (e.g., taking logarithms), estimation of reference limits should be based on nonparametric techniques. With a distribution of any shape, the upper reference limit for the population is obtained through inverting the cumulative distribution function F(x). Precisely speaking, this means that, given the value of the coverage proportion q (usually chosen as q = 0.95 or q = 0.975), one has to find the smallest value of X which satisfies the condition F(x) ≥ q. Denoting the solution by x q , the process of determining x q is easily visualized graphically (see Figure 1A ). Assuming F(x) to be continuous, the lower reference limit for the population, say , q x is obtained through performing the same step with the function 1-F(x) instead of F(x) itself ( Figure 1B ). Adapting this rule for the computation of reference limits with the data obtained from a sample of non-diseased subjects only requires substituting the empirical for the theoretical population distribution function, taking into account that the former will never be continuous but a step function increasing from left to right. As will be illustrated in the subsequent example, computing the nonparametric estimates of x q and q x eventually reduces to sorting the measured values X 1 ,...,X n in ascending order and picking from the resulting list of ordered values some specific element to be identified by means of a simple rule as conforming with the pre-specified coverage proportion q.
An illustrating example for a standard application of both estimation procedures
The following illustration uses parts of the data set published in Appendix 4.2 of the book by Harris and Boyd [4] . After elimination of a few data lines containing outliers it consists of the results of performing routine clinical chemistry in n = 593 male medical students. Both estimation procedures will be demonstrated for blood urea nitrogen (BUN), serum creatinine (SCR) and uric acid (UA) (given in mg/dL). Computing the standard descriptive statistics with these data gave the values shown in Table 1 .
Although one-sided reference intervals for these markers will rarely be considered in practice, their computation will be demonstrated here as well.
Parametric estimates for q = 0.95
With the data of Table 1 , the lower and upper onesided reference limit for BUN is computed to be X ̅ - Nonparametric estimates for q = 0.95
With the same specification of the target coverage proportion as in the parameteric case and n = 593, there holds n · q = 563.35 and n · ((1+q)/2) = 578.175. Rounding these numbers up to the nearest integer yields for the ranks of the order statistics determining the upper nonparametric 95% reference limits in the one-and two-sided cases the values r 1 = 564 and r 2 = 579, respectively. The corresponding ranks for determining the lower reference limits are 1 r = n+1-r 1 = 594-564 = 30 and 2 r = n+1-r 2 = 594-579 = 15. All what remains to do is to identify the order statistics associated with these ranks in the list (being not reproduced here) of the ascending sorted measurement values, yielding the entries in Table 3 . An alternative approach to determining the nonparametric estimates of all reference limits of interest as suitable order statistics actually observed in the sample is the so-called interpolation method (averaging the values of adjacent order statistics). However, the latter is not in line with basic statistical usage and has the disadvantage of producing results with more significant decimal figures than contained in the individual measurements.
Sample size planning of reference value studies
Until fairly recently, the topic of sample size calculation for reference value studies was not given much attention in the biostatistical literature. In view of this it is not surprising that in the practice of laboratory medicine, sample size planning is still mostly done by means of rather crude rules of thumb. One of these rules specifies that n should not be smaller than 120 since otherwise the exact nonparametric CI for the lower limit of the 95% reference interval cannot be calculated [5] . Another proposal being, from a statistician's viewpoint, likewise largely ad hoc requires n to be determined in a way ensuring that the width of the 90% CI for either one of both reference limits does not exceed some specified proportion (e.g., 20%) of the length of the theoretical reference interval for the underlying population [6, 7] . None of these criteria enables one to ensure that the coverage proportion provided by the reference interval estimated from the sample to be drawn comes satisfactorily close to the target value q with high probability. An approach being tailored to fill this gap has been developed in [8] . The following description of the rationale of the procedure (see also the flowchart shown below as Figure 2 ) primarily applies to the planning of studies aiming to establish an upper reference limit.
Step 1: Specification of tolerances δ 1 and δ 2 for the deviation of the actual coverage proportion from its target value q to the left and right, respectively. If, for example, one is willing to accept that the proportion of values in the underlying population covered by the estimated reference region becomes as small as 94% and 96% at most with q chosen as 95%, this would mean that both δ′s were set equal to 1%. Although in principle there is no need to set both δ′s to a common value, we assume in the sequel that the same difference is to be tolerated in both directions so that the subscript will be omitted. A good guidance for choosing the numerical value of δ is to keep fixed the ratio to 1-q at the same value, implying, that if ± 0.01 is thought to be appropriate for q = 0.95, in another application with q = 0.99, one should specify δ = 0.002, and so on. A much more liberal specification is to set both Δs equal to 0.04 when the target coverage is q = 0.95. Then, the proposed criterion essentially ensures with high probability that the specificity which should be 95%, neither exceeds that of a reference interval with coverage 99% nor fails to be at least as large as that of an interval with one-sided coverage 90%. As can be seen from the entries in the first row of Table 4 the sample sizes required in order to satisfy the criterion in this weakened form are only about half as large as the traditionally recommended lower bound of 120 even when the nonparametric estimation procedure shall be used.
Step 2: Specifying a lower bound β (e.g., 90%) to the probability that the coverage proportion attained by the estimated reference region complies with the tolerances specified in Step 1. In [8] , this probability whose role in planning a reference value study is largely analogous to that of power in statistical hypothesis testing, is termed 'confidence probability' (not to be confused with the confidence level associated with a CI for some distributional parameter [3] ).
Step 3: Exploiting the functional relationship between the confidence probability and the sample size for determining by means of a simple iteration process the minimum value of n required to guarantee that the former becomes at least as large as specified in Step 2.
Step 3 can be carried out in a numerically exact manner. A selection of exactly calculated sample sizes for β = 0.90 and common value δ of the tolerances δ 1 and δ 2 is shown in Table 4 . As has to be expected, it turns out that given the value of the target coverage q and the prespecified lower limit β to the confidence probability, the required sample size increases with decreasing tolerance δ. Furthermore, ceteris paribus, the sample size required for a reference value study to be evaluated by means of the nonparameteric method, is up to 2.5 times larger than that required in the parametric case.
Alternatively, Step 3 can be carried out by means of the approximation formulae Figure 2 Flowchart of the procedure of (approximate) sample size computation in the age-independent case. Numbers typed in blue hold for the example presented in the text. In these approximate equations, z 1 and z 2 stands for the 100 · q -and 100 · ((1+β)/2) -percentage point of the standard normal distribution, respectively, and j denotes the ordinate of the standard normal density function at x = z 1 .
Remarkably, the sample sizes calculated by means of the approach described in the preceding paragraph hold likewise for studies aiming to establish a lower instead of an upper reference limit. If the focus lies on reference intervals bounded on both sides, the following procedure can be applied: The same formulae as in the one-sided case are used, but with halved tolerances and q and ß replaced with (1+q)/2 and (1+β)/2, respectively. According to this latter rule, the values of n appearing in the third line from bottom of Table 1 (i.e., n = 272 and n = 636) are sufficient for determining a two-sided reference interval of coverage q = 95% with tolerances 2% and confidence probability of ß = 80% at least.
Example illustrating the use of the approximation formulae
Let us assume that the protocol of a reference value study under planning specifies q = 0.95, δ = 0.01, β = 0.90. The z-values appearing in the formulae are both equal to 1.645, then, and j is computed to be ϕ π
Plugging in these values yields:
( 1 0.5 1.645 ) (0.1031 1.645 /0.01) 676.82, 
Reference regions for agedependent diagnostic markers
In not a few clinical disciplines, it is more the rule than the exception that the reference limits of a diagnostic marker have to depend on age or some other covariable of the continuous type. As becomes obvious from the example shown in Figure 3A , using the same reference limits for all ages would lead to grossly misleading conclusions. Of the PAPP-A concentrations measured later than at a gestational age of 90 days, only a single one would be classed as substantially less than normal whereas for younger gestational ages, the proportion of such values would be almost twice as large as the usually required false positive rate of 5%. In principle, it is fairly clear of what shape a 'reasonable' reference region should be in the situation of Figure 3A . The boundaries of the reference band must be given by curves which increase from left to right, and the width of the band should likewise be an increasing function of time since the same holds true for the variance of the measurement values. However, making these notions precise in terms of a statistical algorithm is a comparatively demanding task involving computationally intensive techniques. In the original biostatistical literature several approaches to the construction of agedependent reference centiles have been proposed which differ distinctly both in terms of the underlying principles and the algorithms required for their implementation. Most frequently applied are smoothed age-specific X ̅ ± 1.96· S ranges for normally distributed observations [10, 11] or data which can be normalized through applying a Box-Cox type transformation [12, 13] , procedures based on the nonparametric quantile regression [14] , and a strictly distribution-free construction which ensures that the proportion of values covered by the band in the empirical joint distribution of age and the diagnostic marker of interest always coincides with the pre-specified target coverage proportion q [15] . In this introductory exposition, we confine ourselves to give an outline of the last of these approaches which has successfully been applied in a multitude of settings, in particular within the field of prenatal medicine (cf. [16] ).
Major steps of a distribution-free construction of reference bands for age-dependent diagnostic markers
Step 1: Fitting a linear regression model in order to determine a central line around which the band is to be spanned. The form of this regression function must reflect the way in which the age-specific means change over time. In absence of specific knowledge about the mechanism which underlies this process, an ordinary polynomial of sufficiently high degree will usually be appropriate.
Step 2: Determining the ratio between the bandwidth at the beginning, around the middle and at the end of the interval within which the measurements were taken, in a way which reflects possible differences in variability between these parts of the time range.
Step 3: Calculating (by means of an iteration algorithm) the minimum width of a band of the form resulting from Steps 1 and 2 guaranteeing coverage of at least q = 90% of the data points in the sample. In cases where the distribution of the measurement values lacks symmetry, the proportions of values lying above and below the band are controlled separately, subject to the condition that both of them are approximately equal to 5%. Thus, the ordinates of the points on the upper and lower boundary will correspond to smoothed 5th and 95th percentiles, respectively. For the PAPP-A data of Figure 3A , the 90% reference band obtained by means of the distribution-free approach is shown in Figure 3B .
Discussion
Even when the diagnostic marker under consideration is technically easy to measure, acquiring a database of sufficiently large size for a reference value study is often a serious problem. Diagnostic laboratories usually have easy access to blood samples from patients. However, the gold-standard design for a reference value study requires persons free from certain diseases or having at least a well-defined health status and showing sufficient variability with respect to age and sex to be recruited. However, in practice, appropriate and in particular complete information regarding the health status is in most cases of out-patients and inpatients not available. The time and effort to be spent on obtaining the data needed and to remove diseased individuals from such a mixed population seems often forbidding. Students as reference individuals have the disadvantage of the limited age range. Thus, there are many obstacles in recruiting subjects for reference value studies making sample size planning a major issue, except one explicitly admits to base reference limit estimation on samples consisting of mixtures of diseased and non-diseased individuals. Unfortunately, such an indirect approach (cf. [17] ) necessarily requires to rely on model assumptions which are not open to direct empirical validation. Concerning the question of whether or not it is admissible to tolerate in a study to be evaluated by means of direct methods a certain amount of values measured in diseased individuals rather than healthy controls, no general recommendations can be given. Nevertheless, it is clear that the proportion of values from diseased individuals should be as low as possible. In order to protect oneself against the potential biases entailed in estimating reference limits with samples including also diseased individuals, it is advisable to rely on statistical methods which, like the nonparametric estimation procedure described above, are robust against outliers. However, it is worth highlighting that the distributions which a diagnostic marker follows in diseased individuals and healthy controls, respectively, might exhibit considerable overlap in which case outlier robustness of the estimation procedure will not be sufficient for solving the problem. Moreover, our results on sample size calculation imply that the price to be paid for using nonparametric rather than parametric methods of reference limit estimation is substantial. In view of this, it is important to note that given biases due to inclusion of values from diseased individuals is not an issue, application of standard parametric methods is also admissible when the assumption is warranted that the distribution of the diagnostic marker under consideration is not normal itself but can be normalized through applying some mathematical transformation (e.g., the log transformation) to the primary measurements. Whenever this holds true, it is recommendable to calculate reference limits on the transformed scale by means of parametric methods and eventually retransform the results by means of the inverse of the respective transformation (taking, e.g., It is also worth noticing that the methods described in this article only apply to studies dealing with a single quantitative marker. In order to account for the often more realistic scenario that in diagnosing some given disease several different markers are considered taking a positive diagnostic decision if at least one of these markers turns out to exceed its reference limits, multivariate reference regions of ellipsoidal (see, e.g., [18] ) or rectangular shape [19] are needed. Such multivariate reference regions enable one to control, in analogy with multiple testing of statistical hypotheses (cf. [20] ), the 'multiple risk of a false positive diagnostic decision' which should not exceed the usual bound of 5% (corresponding to a 'multiple specificity' of at least 95%).
Another generalization of the methods discussed in this paper is required when an age-independent marker is repeatedly measured at several different points of time so that the data upon which the diagnostic decision relies, consist of longitudinal profiles. As was shown in [21] , the distribution-free procedure used to construct the reference band shown in Figure 3B can be modified in such a way that it yields reference bands for longitudinal data as well.
A currently open question is whether and in what way the criterion of estimation precision underlying Table 1 can be adopted for the estimation of age-dependent reference centiles and the sample size planning of studies dealing with age-dependent diagnostic markers.
As a concluding remark, we point out that there are reasons to expect that the majority of diagnostic markers to be assessed in laboratory medicine actually depend in a systematic way on age (or some other covariable). In view of this, it seems tempting to examine also those laboratory parameters which traditionally are assessed by comparing them for all ages with the same reference limits, for the possibility of improving the diagnostic accuracy attainable by means of them through using a reference band of the kind constructed in the preceding section for a sample of PAPP-A values.
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